Houlihan Lokey Advises Inflexion

Houlihan Lokey is pleased to announce that Inflexion Private Equity Partners LLP (Inflexion) has acquired SteriPack Group Ltd. (SteriPack), a leading global contract manufacturer serving the medical device, pharmaceutical, and diagnostic markets. The sponsor signed a definitive purchase agreement on 1st July 2022 and the transaction closed on 25th July 2022.

Founded in 1999, Inflexion is a leading middle-market private equity firm investing in high-growth, entrepreneurial businesses with ambitious management teams and working in partnership with them to accelerate growth. With £7.1 billion in assets under management, Inflexion’s flexible approach allows it to back both majority and minority investments, typically investing £10 million to £400 million of equity in every deal. Today, Inflexion has backed more than 100 businesses in over 160 countries. Inflexion generates value for all stakeholders, with 29,000 employees and an average twofold increase in headcount across its portfolio.

Founded in 1994, SteriPack provides outsourced design, development, manufacturing, assembly, packaging, sterilisation, and supply chain services for medical device, diagnostic, and pharmaceutical businesses, producing a range of products. The company has more than 650 employees in Ireland, Poland, Malaysia, and the US, and has over 100 global clients. The funding from Inflexion will support the business to continue to scale globally as it benefits from strong market growth and further international expansion opportunities. SteriPack is also well placed to undertake further acquisitions with the support of Inflexion, having acquired New Jersey-based HS Design in February 2021 and Colorado-based Halleck-Willard, Inc., in October 2021.

Houlihan Lokey served as the exclusive M&A and financing advisor on this transaction. This deal highlights Houlihan Lokey’s leading European healthcare and debt capital market expertise and further demonstrates the firm’s knowledge of the wider medtech space.